Patient’s experience with subcutaneous and oral methotrexate for the treatment of rheumatoid arthritis

BACKGROUND: Despite the prominent position of methotrexate (MTX) in Rheumatoid Arthiris (RA) therapeutics, its real-world effectiveness may be influenced by a relative lack of tolerability or other side effects that physicians may not be aware of but that are bothersome to patients. The aim of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Curtis, J. R., Xie, F., Mackey, D., Gerber, N., Bharat, A., Beukelman, T., Saag, K. G., Chen, L., Nowell, B., Ginsberg, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037591/
https://www.ncbi.nlm.nih.gov/pubmed/27669978
http://dx.doi.org/10.1186/s12891-016-1254-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037591/
https://www.ncbi.nlm.nih.gov/pubmed/27669978
http://dx.doi.org/10.1186/s12891-016-1254-x

Ejemplares similares